about
Interventions for melanoma in situ, including lentigo malignaInterventions for melanoma in situ, including lentigo malignaPolymorphisms of the BRAF gene predispose males to malignant melanomaPredictive factors for immunotherapy in melanomaKi-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.Repressing CD147 is a novel therapeutic strategy for malignant melanoma.Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining toolSkin biopsy rates and incidence of melanoma: population based ecological studyOverdiagnosis in cancer.Patterns of neural differentiation in melanomas.Insulin-like growth factor system and sporadic malignant melanoma.Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.Sun protection practices and sun exposure among children with a parental history of melanoma.Knowledge, perceptions, and practices of chiropractic interns in the early detection of atypical moles.Melanoma: Molecular Pathogenesis and Therapeutic ManagementSlow-growing melanoma: Report of five cases.The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.Cutaneous melanoma in situ: translational evidence from a large population-based studyStem cells in melanoma developmentCancer stem cells and human malignant melanomaMalignant melanoma: from cell kinetics to micrometastases.Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.Is the Global Solar UV Index an effective instrument for promoting sun protection? A systematic review.Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.Adenovirus siMDM2 and NDRG2 Gene Therapy Inhibits Cell Proliferation and Induces Apoptosis of Squamous Cell Carcinoma.CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.Fine-needle biopsy as a diagnostic technique for metastatic melanoma.TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients.WT-1 expression in a spectrum of melanocytic lesions: Implication for differential diagnosis.Incidence of cutaneous malignant melanoma in Denmark, 1978-2007.The dynamics of death in melanoma.Sun protection practices among children with a family history of melanoma: a pilot study.
P2860
Q24187170-9E7EDC32-0DD8-426E-A97A-1CD0B99EA851Q24202030-AE428511-4451-4CF8-80B6-7B1256E06278Q24806439-F2FE0C9F-77E5-465A-9115-A1C7F1E9AE56Q26778765-6D06470B-985C-4439-9748-93CC54D647ECQ33557480-837B691D-12A0-474C-ADE5-07B00D6F7DACQ33649045-F52C7948-5D86-4CA1-9CAC-25946CECC8D9Q33728046-4803DF79-ADFA-4CB5-98EC-3B9D5E43466CQ33941763-3D8DED44-4FB8-4770-BBCB-DC4EAC5E1AD8Q34111655-78E218A2-FBC3-4CB7-8D65-A6B3B2DFFCF3Q34383962-1E902ADA-E534-4C34-8493-C3A0D6A09318Q34756364-0663B642-4D8F-406F-880D-13D0AF2F0DA9Q34855293-759D9902-39F2-4157-8704-07AA54E02B97Q34970714-4DDE9BBC-DB43-4D70-B87C-F564247FE347Q35032073-E9F09E1E-6DB3-4B66-8754-4B3F72F0447BQ35137163-6D1181B6-7836-4249-87DF-A800FCDD0435Q35169700-446E46B6-A40C-4843-A006-AA0FC9B47E83Q35216430-E59A26CD-6EC3-428B-B1C7-E387ABB68038Q35584985-8C6AC684-BB0D-4C29-91CD-863F72880C1AQ36117797-99839B08-1E21-4124-B5D9-FA7C2E97FDD3Q37114128-F07411CF-4E1C-423B-BE10-9E68AA4170A4Q37818162-B61F545D-7FEE-45EC-AF41-0DC5ECCE8661Q37886997-BAEF8CC3-37D7-4F46-A873-FBD326702BD6Q37897814-0EC5F11D-354A-46D2-96DB-0CAE72569255Q38010057-CAC402EE-8BE7-42CA-BFBF-F479C6BD081AQ38327993-7A067577-5319-45E4-A2E1-7C028D7D0D2FQ38469059-12F27266-4E54-4655-84A2-8E4F2D32E86CQ38761256-645E14A6-DE17-48A7-B900-0358C407DBD6Q39357838-C6AC8199-99BE-4760-A638-DAD6150A1642Q40138603-FE87F396-B692-4456-8BF1-42935D0D4AA4Q40420126-041A047C-5DD7-403F-8657-6CE3402B14E3Q41834211-34D68CE3-0252-4DF3-958D-3926F2919CBDQ43443525-2745AC51-6A7A-4377-B88A-652B157C4C4DQ46449324-FD3D167D-AEE1-4597-A9AB-678D021165F2Q46469982-68D94732-D143-419B-B751-0CF093023B1D
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The melanoma epidemic: res ipsa loquitur.
@ast
The melanoma epidemic: res ipsa loquitur.
@en
type
label
The melanoma epidemic: res ipsa loquitur.
@ast
The melanoma epidemic: res ipsa loquitur.
@en
prefLabel
The melanoma epidemic: res ipsa loquitur.
@ast
The melanoma epidemic: res ipsa loquitur.
@en
P1433
P1476
The melanoma epidemic: res ipsa loquitur.
@en
P2093
Frederick C Beddingfield
P304
P356
10.1634/THEONCOLOGIST.8-5-459
P577
2003-01-01T00:00:00Z